IL17A and type 2 diabetes mellitus: T2D patients have been reported to exhibit a decrease in NK, Th2, and regulatory T cells, an increase in Th1 and Th17 cells2,3, and a higher production of inflammatory cytokines such as IFN-γ, IL-17, and TNF-α4.